Monday, January 31, 2022 10:23:47 AM
Is it high risk...absolutely...if the regulators even get a whiff of Martin being involved in this in any way, it could be a disaster....but...with high risk comes the potential for high reward.
Leronlimab seems to draw a LOT of investor interest, take that interest and combine it with the microscopic float of RGMP.... and just simply due to the law of supply and demand.... the pps could fly.
I don't know what's going on with Martins stake in Phoenixus, sooner he's bought out the better as far as I'm concerned....but as long as he stays out of RGMP business, I like the odds.
FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM